Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Lung Neoplasms|Gastrointestinal Neoplasms
Interventions: DRUG: Motexafin Gadolinium
Sponsor: Pharmacyclics LLC.